Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

W. R. Berkley logoW. R. Berkley WRB

The company said the consolidated loss ratio for Q3 2025 was 62.4%, the same as 2024. The Insurance segment's loss ratio was 63.9%, compared with 63.1% in the prior year, while the Reinsurance & Monoline Excess segment's was 51.3%, compared with 57.0% in the prior year.

10-QQuarterly reportFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said the consolidated loss ratio for Q3 2025 was 62.4%, the same as 2024. The Insurance segment's loss ratio was 63.9%, compared with 63.1% in the prior year, while the Reinsurance & Monoline Excess segment's was 51.3%, compared with 57.0% in the prior year.

  2. The company said favorable prior year reserve development (net of additional and return premiums) for the 9 months ended 2025 was $2 million. Favorable development of $34 million in the Reinsurance & Monoline Excess segment was largely offset by adverse development of $32 million in the Insurance segment.

  3. The company said adverse prior year reserve development in the Insurance segment during the 9 months ended 2025 was driven by other liability and auto liability. It said auto-related claims are being particularly impacted by social inflation.

  4. The company said operating cash flow for the 9 months ended 2025 was $2,587 million, down from $2,868 million for the same period in 2024. It cited increased payments of losses and loss expenses as the primary factor, adding that increased collection of premiums partially offset the decline.

Key figures

Quarter ended September 30, 2025

Revenue
$3.8B
Net income
$511M
EPS
$1.28

From the XBRL financial data filed with the SEC · not processed by AI.

Summary

AI-written

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

Quarterly Loss Ratio 62.4%, Variance by Segment

The company said the consolidated loss ratio for Q3 2025 was 62.4%, the same as 2024. The Insurance segment's loss ratio was 63.9%, compared with 63.1% in the prior year, while the Reinsurance & Monoline Excess segment's was 51.3%, compared with 57.0% in the prior year.

Source · Based on the MD&A text of the filing

9-Month Net Favorable Prior Year Development $2 million

The company said favorable prior year reserve development (net of additional and return premiums) for the 9 months ended 2025 was $2 million. Favorable development of $34 million in the Reinsurance & Monoline Excess segment was largely offset by adverse development of $32 million in the Insurance segment.

Source · Based on the MD&A text of the filing

Insurance Segment Adverse Development and Social Inflation

The company said adverse prior year reserve development in the Insurance segment during the 9 months ended 2025 was driven by other liability and auto liability. It said auto-related claims are being particularly impacted by social inflation.

Source · Based on the MD&A text of the filing

9-Month Operating Cash Flow Declined to $2,587 million

The company said operating cash flow for the 9 months ended 2025 was $2,587 million, down from $2,868 million for the same period in 2024. It cited increased payments of losses and loss expenses as the primary factor, adding that increased collection of premiums partially offset the decline.

Source · Based on the MD&A text of the filing

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.